Does SIGYN THERAPEUTICS, INC. have an economic moat?

Based on its FY2024 SEC filings, the Moat Index scores SIGYN THERAPEUTICS, INC. (SIGY) 34.3 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 80, returns on capital 0, balance-sheet safety 28, capital discipline 24.

How has SIGY's Moat Score changed over time?

The record logs 2 readings since Jul 17, 2026; the latest reads 34.3 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

The Moat Index

SIGYN THERAPEUTICS, INC.

SIGY · Healthcare · $40134 mkt cap · FY2024 filings · No moat ·

Doesn't clear the bar

No moat

The four filters

Pricing power80

Median gross margin 65.9% over 4y, variable.

Returns on capital0

Median ROIC -2680.4%, above the 9% hurdle in 0% of years.

Balance-sheet safety28

Net debt/EBITDA n/ax, interest coverage 0x.

Capital discipline24

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale

No price data

Owner earnings (normalized): —
Est. intrinsic value / share: —
Recent price: $0.03
Discount to value: No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

Fundamentals

There's no normalized fundamentals series for SIGY yet — it appears once ingest has processed its filings.

Moat Score history

Moat Score over timeLast scored reading of each day, on the 0–100 scale34.3 / 100

Score history begins Jul 17, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — SIGY has read No moat for every logged capture since Jul 17, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Healthcare context

#314 of 440 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

#312LNSR LENSAR, Inc.34.4 out of 100, No moatNo moat
#313NTRA NATERA, INC.34.4 out of 100, No moatNo moat
#315MLAB MESA LABORATORIES, INC.34.2 out of 100, No moatNo moat
#316AMRN AMARIN CORP PLC\UK34.2 out of 100, No moatNo moat

Compare SIGY with its nearest peers →All Healthcare companies on the Index →

Common questions about SIGY

Does SIGYN THERAPEUTICS, INC. have an economic moat?: Based on its FY2024 SEC filings, the Moat Index scores SIGYN THERAPEUTICS, INC. (SIGY) 34.3 out of 100 — below the Shallow-moat bar, so no moat. The four filters behind that score (each 0–100): pricing power 80, returns on capital 0, balance-sheet safety 28, capital discipline 24.
How has SIGY's Moat Score changed over time?: The record logs 2 readings since Jul 17, 2026; the latest reads 34.3 out of 100 (no moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.

Embed this score on your site

One iframe, no script. The badge shows SIGY’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/SIGY"
  width="340" height="150" style="border:0"
  title="SIGY Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell SIGY. See the disclaimer.